Last edition
News about "Gilead"
Lupin Receives Tentative Approval from US FDA for its HIV treatment tablets
Lupin has received tentative US FDA approval for Bictegravir, Emtricitabine and Tenofovir Alafenamide Tablets to treat HIV, bioequivalent to Gilead’s Biktarvy, for adults and paediatric patients over 25 kg.
Gilead | 25/09/2025 | By Dineshwori
Gilead breaks ground on new manufacturing hub as part of USD 32 billion US investment plan
Gilead Sciences has begun construction of a new Pharmaceutical Development and Manufacturing hub at its headquarters in Foster City, California, as part of a USD 32 billion investment programme to expand its manufacturing capabilities in the United States.
Gilead | 05/09/2025 | By Darshana | 203
Cognizant Extends Alliance with Gilead to Boost Advanced Technology Applications
Gilead is expected to enhance its efficiency through leveraging Cognizant's expertise in AI and advanced technology applications.
Gilead | 03/02/2025 | By Aishwarya | 259
Positive nod from FDA for Gilead's Maryland site
Gilead targets 400 jobs, assembles cell therapy manufacturing troika with FDA nod for Maryland site.
Gilead | 23/04/2022 | By Sudeep Soparkar | 867
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy